← Leaderboards
Brian Wigdahl
Drexel University
$23,790,183
Attributed
$28,019,839
Total exposure
18
Grants
14
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.6M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$28,019,839 · 18
By mechanism
R01$21,296,989 · 5
P30$5,531,645 · 4
U19$593,644 · 2
R13$332,294 · 5
P01$265,267 · 2
Top collaborators
- Jonathan Karn5 shared
- Ilker Kudret Sariyer5 shared
- Kamel Khalili4 shared
- Pooja Jain2 shared
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsInfectionViralMicrogliaHiv-1MacrophageGene ExpressionMonocyteBrainInvestigationPeripheral BloodNeuraxisVirusVirus GeneticsAstrocytesClinical ResearchMolecularPreventAntiretroviral TherapySamplingGenesViral ProteinsGenomeTissues
Grant awards (84)
Broad-spectrum HIV gene editing strategies in peripheral and brain reservoirs$678,047
R01 · FY2025 · MH · contact PI
Clinical and Translational Research Support Core for Institution # 269291$462,989
P30 · FY2025 · MH · contact PI
Cancer Genomics Shared Resource$1
P30 · FY2025 · CA · contact PI
Broad-spectrum HIV gene editing strategies in peripheral and brain reservoirs$682,558
R01 · FY2024 · MH · contact PI
Clinical and Translational Research Support Core for Institution # 269291$405,723
P30 · FY2024 · MH · contact PI
Cancer Genomics Shared Resource$1
P30 · FY2024 · CA · contact PI
Broad-spectrum HIV gene editing strategies in peripheral and brain reservoirs$685,406
R01 · FY2023 · MH · contact PI
Clinical and Translational Research Support Core for Institution # 269291$462,989
P30 · FY2023 · MH · contact PI
Broad-spectrum HIV gene editing strategies in peripheral and brain reservoirs$704,060
R01 · FY2022 · MH · contact PI
Clinical and Translational Research Support Core for Institution # 269291$250,000
P30 · FY2022 · MH · contact PI
Gene editing strategies to target HIV for elimination in periphery and brain$754,319
R01 · FY2020 · MH · contact PI
Clinical Core$615,347
P30 · FY2020 · MH · contact PI
Gene editing strategies to target HIV for elimination in periphery and brain$757,056
R01 · FY2019 · MH · contact PI
Clinical Core$624,927
P30 · FY2019 · MH · contact PI
Gene editing strategies to target HIV for elimination in periphery and brain$762,407
R01 · FY2018 · MH · contact PI
Clinical Core$647,107
P30 · FY2018 · MH · contact PI
Gene editing strategies to target HIV for elimination in periphery and brain$767,557
R01 · FY2017 · MH · contact PI
Clinical Core$637,479
P30 · FY2017 · MH · contact PI
Gene editing strategies to target HIV for elimination in periphery and brain$804,035
R01 · FY2016 · MH · contact PI
Clinical Core$686,484
P30 · FY2016 · MH · contact PI
International HIV Medicine Core$142,366
P30 · FY2015 · MH · contact PI
High Specificity HIV-1 Markers Predictive of Neuro-AIDS$670,287
R01 · FY2014 · DA · contact PI
International HIV Medicine Core$144,267
P30 · FY2014 · MH · contact PI
High Specificity HIV-1 Markers Predictive of Neuro-AIDS$643,083
R01 · FY2013 · DA · contact PI
HTLV-1 & Cellular Factors in Neuroinflammatory Disease$282,037
R01 · FY2013 · CA · contact PI
International HIV Medicine Core$140,305
P30 · FY2013 · MH · contact PI
High Specificity HIV-1 Markers Predictive of Neuro-AIDS$670,363
R01 · FY2012 · DA · contact PI
HTLV-1 & Cellular Factors in Neuroinflammatory Disease$300,039
R01 · FY2012 · CA · contact PI
International HIV Medicine Core$148,056
P30 · FY2012 · MH · contact PI
High Specificity HIV-1 Markers Predictive of Neuro-AIDS$670,799
R01 · FY2011 · DA · contact PI
HIV-1 LTR Activation in Peripheral Blood and Brain$367,500
R01 · FY2011 · NS · contact PI
International HIV Medicine Core$163,604
P30 · FY2011 · MH · contact PI
High Specificity HIV-1 Markers Predictive of Neuro-AIDS$674,397
R01 · FY2010 · DA · contact PI
HIV-1 LTR Activation in Peripheral Blood and Brain$371,250
R01 · FY2010 · NS · contact PI
HTLV-1 & Cellular Factors in Neuroinflammatory Disease$291,300
R01 · FY2010 · CA · contact PI
HIV-1 LTR Activation in Peripheral Blood and Brain$375,000
R01 · FY2009 · NS · contact PI
HTLV-1 & Cellular Factors in Neuroinflammatory Disease$291,300
R01 · FY2009 · CA · contact PI
9th International Symposium on NeuroVirology$73,019
R13 · FY2009 · MH · contact PI
Co-evolution of HIV-1 Regulators in CNS Disease$20,673
R01 · FY2009 · NS · contact PI
HIV-1 LTR Activation in Peripheral Blood and Brain$18,251
R01 · FY2009 · NS · contact PI
HIV-1 LTR Activation in Peripheral Blood and Brain$375,000
R01 · FY2008 · NS · contact PI
High Specificity HIV-1 Markers Predictive of Neuro-AIDS$348,456
R01 · FY2008 · DA · contact PI
Co-evolution of HIV-1 Regulators in CNS Disease$337,790
R01 · FY2008 · NS · contact PI
HTLV-1 & Cellular Factors in Neuroinflammatory Disease$291,300
R01 · FY2008 · CA · contact PI
HIV-1 LTR Activation in Peripheral Blood and Brain$375,000
R01 · FY2007 · NS · contact PI
High Specificity HIV-1 Markers Predictive of Neuro-AIDS$355,567
R01 · FY2007 · DA · contact PI
Co-evolution of HIV-1 Regulators in CNS Disease$337,790
R01 · FY2007 · NS · contact PI
HTLV-1 & Cellular Factors in Neuroinflammatory Disease$291,300
R01 · FY2007 · CA · contact PI
In vitro and in vivo anti-HIV-1 activity of single- and multi-component biguanide$212,860
U19 · FY2007 · AI · contact PI
8th International Symposium on NeuroVirology$66,500
R13 · FY2007 · MH · contact PI
High Specificity HIV-1 Markers Predictive of Neuro-AIDS$366,188
R01 · FY2006 · DA · contact PI
Co-evolution of HIV-1 Regulators in CNS Disease$347,879
R01 · FY2006 · NS · contact PI
HTLV-1 & Cellular Factors in Neuroinflammatory Disease$300,000
R01 · FY2006 · CA · contact PI
Anti-HIV-1 activity of single & multicomponent biguanide$129,266
U19 · FY2006 · HD · contact PI
7th International Symposium on NeuroVirology$60,500
R13 · FY2006 · MH · contact PI
High Specificity HIV-1 Markers Predictive of Neuro-AIDS$375,000
R01 · FY2005 · DA
Co-evolution of HIV-1 Regulators in CNS Disease$356,250
R01 · FY2005 · NS
HIV 1 LTR Activation in Peripheral Blood and Brain$341,816
R01 · FY2005 · NS
REGULATION OF HTLV I LTR IN IMMUNE AND NERVOUS SYSTEMS$316,875
R01 · FY2005 · CA
Anti-HIV-1 activity of single &multicomponent biguanide$127,373
U19 · FY2005 · HD
High Specificity HIV-1 Markers Predictive of Neuro-AIDS$375,000
R01 · FY2004 · DA
Co-evolution of HIV-1 Regulators in CNS Disease$356,250
R01 · FY2004 · NS
HIV 1 LTR Activation in Peripheral Blood and Brain$341,946
R01 · FY2004 · NS
REGULATION OF HTLV I LTR IN IMMUNE AND NERVOUS SYSTEMS$316,875
R01 · FY2004 · CA
Anti-HIV-1 activity of single &multicomponent biguanide$124,145
U19 · FY2004 · HD
HIV 1 LTR Activation in Peripheral Blood and Brain$333,602
R01 · FY2003 · NS
REGULATION OF HTLV I LTR IN IMMUNE AND NERVOUS SYSTEMS$322,766
R01 · FY2003 · CA
HIV Molecular &Clinical Neuroscience Workshop$77,275
R13 · FY2003 · MH
HIV 1 LTR Activation in Peripheral Blood and Brain$342,072
R01 · FY2002 · NS
REGULATION OF HTLV I LTR IN IMMUNE AND NERVOUS SYSTEMS$321,019
R01 · FY2002 · CA
CORE--FETAL TISSUE AND PRIMARY NEUROGLIAL CUTURE$103,525
P01 · FY2002 · NS
4th International Symposium on NeuroVirology$55,000
R13 · FY2002 · NS
IN VITRO AND IN VIVO EFFICACY OF TOPICAL ANTI-HIV VIRUCIDAL STRATEGIES$0
P01 · FY2002 · AI
HIV 1 LTR Activation in Peripheral Blood and Brain$342,195
R01 · FY2001 · NS
REGULATION OF HTLV I LTR IN IMMUNE AND NERVOUS SYSTEMS$317,612
R01 · FY2001 · CA
CORE--FETAL TISSUE AND PRIMARY NEUROGLIAL CUTURE$103,525
P01 · FY2001 · NS
HIV 1 LTR Activation in Peripheral Blood and Brain$50,000
R01 · FY2001 · NS
IN VITRO AND IN VIVO EFFICACY OF TOPICAL ANTI-HIV VIRUCIDAL STRATEGIES$0
P01 · FY2001 · AI
IN VITRO AND IN VIVO EFFICACY OF TOPICAL ANTI-HIV VIRUCIDAL STRATEGIES$0
P01 · FY2001 · AI
NEUROLOGICAL &LYMPHOID FACTORS IN HIV1 LTR ACTIVATION$258,045
R01 · FY2000 · NS
REGULATION OF HTLV I LTR IN IMMUNE AND NERVOUS SYSTEMS$230,892
R01 · FY2000 · CA
IN VITRO AND IN VIVO EFFICACY OF TOPICAL ANTI-HIV VIRUCIDAL STRATEGIES$58,217
P01 · FY2000 · AI
NEUROLOGICAL &LYMPHOID FACTORS IN HIV1 LTR ACTIVATION$30,780
R01 · FY2000 · NS
CORE--FETAL TISSUE AND PRIMARY NEUROGLIAL CUTURE$0
P01 · FY2000 · NS